US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

265.40

+5.212.00%

Post-market: 265.400.00000.00%19:30 EDT

Volume:187.29K

Turnover:49.67M

Market Cap:2.91B

PE:31.06

High:266.02

Open:260.84

Low:260.36

Close:260.19

52wk High:275.23

52wk Low:182.08

Shares:10.95M

Float Shares:10.95M

Volume Ratio:3.02

T/O Rate:1.71%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.04

PE(LYR):7.03

Loading ...

Overview Company News Filings

NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing

Bruker Board Declares Quarterly Cash Dividend for Shareholders

Bruker Declares Quarterly Cash Dividend of $0.05 a Share

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million

Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment

Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing

THOMSON REUTERS

Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing

THOMSON REUTERS

NeoGenomics Announces Planned Transition of General Counsel Role

Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

Veracyte (VCYT) Dropped, So What Is Behind The Latest Attention?

Simply Wall St.

Bruker Expands Atinary Collaboration, Makes Minority Investment in AI R&D Firm

MT Newswires Live

Bruker announces strategic collaboration with Atinary Technologies

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

THOMSON REUTERS

Bruker Corporation - Makes Minority Investment in Atinary; Financial Details not Disclosed

THOMSON REUTERS

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Simply Wall St.

Bruker Takes Majority Stake in Organ-on-a-Chip Developer Mimetas

Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development

THOMSON REUTERS

Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management

THOMSON REUTERS

Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/FBT/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":265.4,"timestamp":1791576000000,"preClose":260.19,"halted":0,"volume":187286,"hourTrading":{"tag":"盘后","latestPrice":265.4,"preClose":265.4,"latestTime":"19:30 EDT","volume":98482,"amount":26137119.92,"timestamp":1791588606585,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.020023828740535685,"floatShares":10950002,"shares":10950002,"eps":8.545272,"marketStatus":"Closed","change":5.21,"latestTime":"10-09 16:00:00 EDT","open":260.84,"high":266.02,"low":260.36,"amount":49674611.178279996,"amplitude":0.021753,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":260.19,"sharesOutstanding":11450002,"nav":260.3,"aum":2837270520.6,"bidAskSpread":0.00087,"preHourTrading":{"tag":"盘前","latestPrice":260.19,"preClose":260.19,"latestTime":"07:58 EDT","volume":3,"amount":780.5699999999999,"timestamp":1791547119615,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":265.4,"preClose":265.4,"latestTime":"19:30 EDT","volume":98482,"amount":26137119.92,"timestamp":1791588606585,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.020693,"impliedVol":0.2454,"impliedVolPercentile":0.9044},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10950002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":3.020693,"shares":10950002,"dividePrice":0,"high":266.02,"amplitude":0.021753,"preClose":260.19,"low":260.36,"week52Low":182.08,"pbRate":"1.04","psRate":"701.07","week52High":275.23,"institutionHeld":0,"latestPrice":265.4,"eps":8.545272,"divideRate":0,"volume":187286,"delay":0,"ttmEps":8.545272,"open":260.84,"prevYearClose":206.52,"prevWeekClose":266.44,"prevMonthClose":272.26,"prevQuarterClose":272.26,"fiveDayClose":266.44,"twentyDayClose":261.85,"sixtyDayClose":249.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659935124","title":"NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659935124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659935124?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:23","pubTimestamp":1786742633,"startTime":"0","endTime":"0","summary":"An announcement from NEO Battery Materials Ltd ( ($TSE:NBM) ) is now available. NEO Battery Materials Ltd. has closed a non-brokered private placem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neo-battery-raises-4-million-to-expand-south-korean-battery-manufacturing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neo-battery-raises-4-million-to-expand-south-korean-battery-manufacturing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","UYM","BK4196","NEO","FBT","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121403","title":"Bruker Board Declares Quarterly Cash Dividend for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121403","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121403?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:58","pubTimestamp":1786741083,"startTime":"0","endTime":"0","summary":"The latest update is out from Bruker ( ($BRKR) ). On August 14, 2026, Bruker Corporation’s Board of Directors declared a quarterly cash dividend of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bruker-board-declares-quarterly-cash-dividend-for-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bruker-board-declares-quarterly-cash-dividend-for-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TINY","BRKR","BK4588","FBT","LU0757428866.USD","LU1815336091.USD","BK4585","VIG","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129910","title":"Bruker Declares Quarterly Cash Dividend of $0.05 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129910","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129910?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:23","pubTimestamp":1786738996,"startTime":"0","endTime":"0","summary":"Bruker declares quarterly cash dividend of $0.05 a shareBruker declared a quarterly cash dividend of USD 0.05 per share on its common stock.Dividend payable Oct. 7, 2026, to shareholders of record at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL69wb3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4121","LU0757428866.USD","LU1815336091.USD","BRKR","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162947","title":"Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162947","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"clinical trial were presented at the 2026 European Hematology Association.  Annual Meeting. Data presented reinforced vispa-cel is the only. single-dose, off-the-shelf therapy to demonstrate deep and durable. responses on par with autologous CAR-T cell therapies in second-line . large B cell lymphoma . Efficacy and safety data in 2L LBCL. patients who had received a single dose of 80 million optimized vispa-cel. -- Optimized vispa-cel is defined as cells from a donor younger than 30. years old with at least two matched human leukocyte antigen  alleles. between patient and donor. The 27-patient subgroup best represents the. treatment regimen and patient population for Caribou's planned ANTLER-3. -- Caribou previously reached alignment with the U.S. Food and Drug. Administration  regarding its planned ANTLER-3 pivotal phase 3. clinical trial design, which is expected to be a randomized, control","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4139","BK4022","CR","BK4585","ORR","FBT","SYNB","IBBQ","NVIB","GNOM","PFS","LFSC","LD","GDOC","HYLG","BK4539","BK4211","BK4588","MEDX","IBB","BK4230","CRBU","IDNA","CAR","TBXU","CNCR","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900794","title":"Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900794","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900794?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:27","pubTimestamp":1786566428,"startTime":"0","endTime":"0","summary":"Corcept Chief Development Officer William Guyer disposes of common shares worth $1.85 millionCorcept disclosed Chief Development Officer William Guyer exercised options for 16,300 shares at $ 21.65 on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2qSVvx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CORT","FBT","LU1559883803.SGD","BK4532","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906555","title":"Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906555?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:19","pubTimestamp":1786547988,"startTime":"0","endTime":"0","summary":"Alkermes cuts interest spreads on $1.52 billion term loan facilities via credit agreement amendmentAlkermes entered an amendment on Aug. 12, 2026 to its Feb. 12, 2026 credit agreement with JPMorgan Chase Bank.The deal covers senior secured term loan A of USD 745.31 million, due Feb. 12, 2031, and term loan B of USD 773.06 million, due Aug. 12, 2031.The amendment cuts the interest spread by 0.75% on the term loan A facility, 0.5% on the term loan B facility.Term loan A now prices at Term SOFR plus 1.75%-2.25%, or base rate plus 0.75%-1.25%, based on secured net leverage.Term loan B now prices at Term SOFR plus 2.25%, or base rate plus 1.25%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3L5Jbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FNCL","PSIL","MEDX","LU0345770993.USD","JPO","TFNS","ALKS","FTXO","IXG","LU0211331839.USD","PSCH","LU2357305700.SGD","LU1162221912.USD","LU2023250843.SGD","LU0106261372.USD","LU0211326755.USD","LU1720051017.SGD","LU2462157665.USD","FBT","LU2106854487.HKD","LU1974910355.USD","LU2054465674.USD","LU1496350502.SGD","IE00BYXW3230.USD","LU2237443622.USD","IE00BZ1G4Q59.USD","IYF","LU1629891620.HKD","LU2456880835.USD","LU0320765646.SGD","XLF","LU1116320901.HKD","VFH","LU2552382215.SGD","TRUF","LU0208291251.USD","IYG","LU0320765489.SGD","KBWB","LU0234572021.USD","LU0496365809.HKD","JPX","LU0265550946.USD","LU1363072403.SGD","JPMO","LU2552382132.HKD","LU2505996681.GBP","LU1551013425.SGD","IBRN","UYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908840","title":"Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908840?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","MEDX","IBRN","PSCH","FBT","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908808","title":"Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908808?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","MEDX","PSCH","IBRN","PSIL","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945652","title":"NeoGenomics Announces Planned Transition of General Counsel Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945652?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:30","pubTimestamp":1786480221,"startTime":"0","endTime":"0","summary":"NeoGenomics ( ($NEO) ) has shared an update. NeoGenomics announced on August 11, 2026, that Alicia Olivo, its EVP, General Counsel & Business Devel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neogenomics-announces-planned-transition-of-general-counsel-role?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neogenomics-announces-planned-transition-of-general-counsel-role?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4121","FBT","NEO","LU0012050646.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657916","title":"Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658657916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:01","pubTimestamp":1786456868,"startTime":"0","endTime":"0","summary":"Neurogene ( ($NGNE) ) just unveiled an announcement. Neurogene reported strong progress in its NGN-401 gene therapy program for Rett syndrome, high...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBBQ","IBB","LFSC","CNCR","FBT","SYNB","BK4585","GNOM","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658550916","title":"Veracyte (VCYT) Dropped, So What Is Behind The Latest Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658550916","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658550916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:32","pubTimestamp":1786451561,"startTime":"0","endTime":"0","summary":"What the latest quarter means for Veracyte stock\nVeracyte (VCYT) drew fresh attention after reporting second quarter results that included revenue of $150.32 million and net income of $25.49 million, alongside a raised full year 2026 revenue outlook to a range of $590 million to $596 million.\nSee our latest analysis for Veracyte.\nVeracyte's second quarter swing to profitability and higher 2026 revenue guidance have arrived after a mixed stretch for the share price, with a 30 day share price...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/veracyte-vcyt-dropped-so-what-is-behind-the-latest-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/veracyte-vcyt-dropped-so-what-is-behind-the-latest-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VCYT","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997406","title":"Bruker Expands Atinary Collaboration, Makes Minority Investment in AI R&D Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997406","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997406?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:54","pubTimestamp":1786449245,"startTime":"0","endTime":"0","summary":"Bruker  said Tuesday it has expanded its collaboration with Atinary Technologies and made a minority investment in the artificial intelligence-driven research and development company.Financial terms of the deal were not disclosed.Atinary plans to integrate Chemspeed laboratory automation platforms, Bruker analytical instruments and SciY scientific software into its AI-driven workflows, Bruker said.The companies aim to combine robotics, analytical technologies and AI agents to automate experiment design and accelerate scientific discovery, Bruker added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1815336091.USD","AIPO","BRKR","QTOC","VTHR","FBT","ARTY","LU0757428866.USD","CHAT","BK4121","TINY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658252992","title":"Bruker announces strategic collaboration with Atinary Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2658252992","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658252992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:15","pubTimestamp":1786446917,"startTime":"0","endTime":"0","summary":"Bruker (BRKR) Corporation announced an expanded strategic collaboration with Atinary Technologies. Financial details were not disclosed. Atinary in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bruker-announces-strategic-collaboration-with-atinary-technologies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bruker-announces-strategic-collaboration-with-atinary-technologies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","BRKR","FBT","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658418994","title":"Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2658418994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658418994?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA70R2HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","LU0757428866.USD","BK4121","BRKR","FBT","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658099446","title":"Bruker Corporation - Makes Minority Investment in Atinary; Financial Details not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2658099446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658099446?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA70R2HL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4121","TINY","LU0757428866.USD","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658011961","title":"Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658011961","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658011961?lang=en_us&edition=fundamental","pubTime":"2026-08-11 11:31","pubTimestamp":1786419097,"startTime":"0","endTime":"0","summary":"Why Bruker stock is back in focus after the latest quarterly update\nBruker (BRKR) is back on investors’ radar after second quarter results combined rising sales with a reported net loss driven largely by impairment charges. Fresh 2026 revenue guidance added another key data point for the stock.\nSee our latest analysis for Bruker.\nBruker’s latest guidance for 2026, combined with the second quarter impairment charges, has come alongside a 25.91% 90 day share price return and an 83.88% 1 year...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-could-be-6-undervalued-after-quarterly-loss-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-could-be-6-undervalued-after-quarterly-loss-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1815336091.USD","BK4121","TINY","LU0757428866.USD","BRKR","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383189","title":"Bruker Takes Majority Stake in Organ-on-a-Chip Developer Mimetas","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383189?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:01","pubTimestamp":1786359686,"startTime":"0","endTime":"0","summary":"Bruker takes majority stake in organ-on-a-chip developer MIMETASBruker took a majority stake in MIMETAS, expanding into organ-on-a-chip microphysiological systems for drug discovery and preclinical te","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7NsKX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BRKR","BK4121","FBT","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980054","title":"Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980054?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","BK4121","LU1815336091.USD","BRKR","FBT","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938953","title":"Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938953?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","FBT","LU1815336091.USD","BRKR","LU0757428866.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658389549","title":"Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2658389549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658389549?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","BK4121","BRKR","FBT","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}